Fascination About mesenchymal stem cells therapy
In contrast to investigations describing the pro-angiogenic outcome of MSCs (Zhang et al., 2013; Li et al., 2016), the anti-tumor activity of MSCs through inhibition of tumor angiogenesis has also been documented. A study noted that bone marrow MSCs prohibit vascular development in ΔGli36 glioma xenograft by means of downregulation on the PDGF/PDG